Results

Total Results: 1,117 records

Showing results for "choice".

141. Pbt-Lsr-Draft-Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbt-lsr-draft-report.pdf
     February 04, 2022 - ) Cannabis Products ..... 23 Summary of Findings for Whole-Plant Cannabis and Mixed (Patient-Choice) … • Evidence on whole-plant cannabis (including patient’s choice of products), low THC to CBD ratio … Key Points for Whole-Plant Cannabis and Mixed (Patient-Choice) Cannabis Products • No new studies … evaluated whole-plant cannabis or mixed (patient-choice) cannabis products … evaluated whole-plant cannabis or mixed (patient-choice) cannabis products.

142. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
     October 01, 2018 - the EPC report and asked about what other information they require to make their decisions about choice … clinicians were instructed to ask patients for the issue most important to them when making a treatment choice … The diabetes mellitus medication choice decision aid: a randomized trial.

143. Decision Aids for Advance Care Planning | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/advanced-care-decision-aids/technical-brief
     July 29, 2014 - Current Page Topic Timeline Dec. 22, 2011 Topic Suggestion Dec. 10, 2013 Research Protocol Jul. 29, 2014 Technical Brief Nov. 3, 2014 Disposition of Comments Report Decision Aids for Advance Care Planning Technical Brief Archived July 29, 2014 Web Version [NLM Site] Download Main Document PDF 511.4 KB …

144. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-250-cannabis-other-plant-based-treatments-evidence-summary.pdf
     October 01, 2021 - • Evidence on whole-plant cannabis (including patient’s choice of products), low- THC to CBD ratio … CBD THC Synthetic THC THC to CBD Ratio Unclear High High Source Any cannabis product (patient’s choice

145. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
     October 01, 2021 - • Evidence on whole-plant cannabis (including patient’s choice of products), low- THC to CBD ratio … CBD THC Synthetic THC THC to CBD Ratio Unclear High High Source Any cannabis product (patient’s choice

146. Hunt_Panel_1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/hunt_panel_1.pdf
     January 01, 2010 - Hunt_Panel_1 Slide  1: Helping  People  Make  Better Health Care  Choices: Why  Web 2.0? Yvonne Hunt, Ph.D., M.P.H. Cancer Prevention Fellow National Cancer Institute, Bethesda, MD Slide  2: Untitled page from the smokefree.gov Web site. Slide  3…

147. Methods Guide for Comparative Effectiveness Reviews - Expanded Guidance on Selected Quantitative Synthesis Topics (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
     March 01, 2013 - 14 percent, 13 percent or 31 percent of 115 meta-analyses of binary outcomes when the measure of choice … Explanation of choice of effect measure Specify what type of outcome data is being combined (e.g … If the study design allows a choice of effect measure then choose the one that best answers the research … question and provide a rationale for that choice. 14 Table 2. … Provide interpretation for the individual and combined study estimates based on the type of data and choice

148. Using Deliberative Methods to Engage the Public: Facilitating a Deliberative Session (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-facilitation-slides-text.pdf
     January 11, 2017 - Concerns about loss of patient/doctor authority o How people balance the tension between personal choice

149. Infantile-Hemangioma Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
     January 01, 2016 - Lesion characteristics such as size, location, and type (e.g., superficial, deep) also influence the choice … timolol, while deep lesions are less likely to respond.13 Intralesional steroids may be the drug of choice … discovery of its effects on IH lesions in 2008.17 Prior to this, corticosteroids were the drug of choice … , but propranolol has become the typical choice for initial medical management in children without … Lesion characteristics also influence the choice of specific pharmacologic agents.

150. Disposition of Comments for Evidence Report #208 Part 5 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
     July 26, 2012 - routinely have publicly reported scores for individual providers, this point about informing consumer choice … emergency or based on a doctor's referral or in a one-hospital region, the consumer isn't making a choice … Additional text has been added explaining that no guidance or prior practice dictated the choice of … Section Comment Response Peer Reviewer 5 Results 1) KQ4: impact on patients: be clear about patient choice … 2) Line 23-34: ‘one reason..’ is unclear how volume and market share is associated with consumer choice

151. Methods Research Report - Meta-Analytical Statistical Inferences for Continuous Measure Outcomes as a Function of Effect Size Metric and Other Assumptions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/statistical-inference_research.pdf
     April 01, 2013 - The current results imply that the choice of effect size metrics, estimators, and sampling variances … Findings relevant to meta-analytic practice (effect size and variance choice) ................30 … If meta-analytic statistics and inferences do depend on choice of unstandardized vs. … Choice of Metric When Meta-Analyzing Continuous Measures Although several statistical methods exist … Findings relevant to meta-analytic practice (effect size and variance choice) Design Type Inferential

152. Ch 2-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
     January 01, 2011 - 21 Abstract The choice of study design often has profound consequences for the causal interpretation … The choice of study design often has profound consequences for the causal interpretation of study results … treatments and outcomes of interest, as well as the predictors of outcome risk potentially related to choice … Choice of Comparators Both confounding by indication and confounding by frailty may be strongest and … Therefore, the choice of an appropriate study design is at least as important, if not more important

153. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
     January 03, 2012 - Comparison Groups An important choice in study design is the selection of suitable treatment and … useful to explore these subpopulations to determine if the overall associations persist or if the best choice … Samy Suissa illustrated how the choice of cohort definition can affect effect estimates in his paper … The precise choice of transformation requires knowledge of the distribution of the covariate. … • Does the choice of statistical method influence the directionality or strength of the association

154. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - The choice of NIT may differ by clinician preference, availability, or setting (outpatient vs. chest … probability, most clinicians would prefer to have patients undergo one NIT prior to determining a treatment choice … Choice of NIT— and whether to use exercise or pharmacological stress imaging—may be influenced by functional … Noncomparative studies have selection, spectrum, and intervention biases for the following reasons: The choice … The information from these clinical trials could inform how the choice of an NIT modality affects prognosis

155. Management of Uterine Fibroids - Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
     December 01, 2017 - For these reasons, the evidence is insufficient to inform choice of expectant management over other … information is required as a first step towards using individual characteristics to inform treatment choice … were randomly assigned to the intervention received, provider and patient biases in intervention choice

156. Test-Performance-Metrics Appendixes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
     January 01, 2005 - informative tests.3 We note that other, more lenient boundaries for LR+ and LR- can be used3 and that the choice

157. S1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s1.pdf
     October 01, 2007 - resulting from the adverse drug effects of medications, suboptimal treatment response, inappropriate choice

158. CER 174 Executive Summary: Imaging for the Pretreatment of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
     April 01, 2016 - dismal at about 6 percent.1 Staging involves determining the extent of disease and guides the choice … Choice of treatment (e.g., surgery, chemotherapy, radiation) b. Timeliness of treatment c. … of test (or test strategy) might influence choice of treatment, timeliness of treatment, harms due … • For comparative choice of treatment (part of KQ2), this means reporting the percentage of patients … who received a specific treatment choice for one test or test strategy compared with another test

159. Payer Perspectives on Improving Usability of Effective Health Care Products: Bridging the Gap Between Information Needs and Evidence Translation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/payer-usability/white-paper
     February 03, 2014 - Payer Perspectives on Improving Usability of Effective Health Care Products: Bridging the Gap Between Information Needs and Evidence Translation White Paper February 3, 2014 Download Main Document PDF 294 KB This report is available in PDF (294 kB) only. People using assistive technology may not be ab…

160. Progestogens-Preterm-Birth Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
     September 01, 2012 - Unresolved issues about choice of progestogen, optimal route of drug delivery, and other candidate high … Ultimately, providing data to support choice of an optimal form of progestogen, to determine whether